Merck a global leader in science and technology is partnered with company builder mantro GmbH (Munich, Germany) to accelerate the establishment of EdiMembre, a Deep-Tech spin-out from Massachusetts, U.S.A., that is poised to disrupt the
The implementation of new policy frameworks, India’s pharmaceutical contract manufacturing industry is emerging as a key player on the global stage,” said Sameer Hiremath, Vice Chairman and Managing Director, Hikal Ltd
According to Saransh Chaudhary, president of Global Critical Care at Venus Remedies and CEO of the Venus Medicine Research Centre, environmental restrictions are desperately needed because antibiotic levels in urban and industrial wastewater around
Xspray Pharma signed a deal with Handa Therapeutics that will give it up to double-digit royalties on Handa's net profits, marking the company's first out-licensing arrangement from its patent portfolio
.jpeg "AN2 Therapeutics Starts First Human Trial of Oral AN2-502998")
AN2 Therapeutics, a company working on new drug tech, shared that it has finished the first round of doses in a test of its new drug, AN2-502998.
STEER World, a global leader in advanced materials platform technology, has successfully demonstrated a 200 kg/hour continuous run of Metformin granules using its patented INTEGRAAL Continuous Granulation System
SCHOTT, the world leader in specialty glass production, has expanded its manufacturing plant in Jambusar, Gujarat, introducing Syringe and cartridge glass tubing made in India. This transforms SCHOTT into the biggest provider of syringe and cartridge
The Central Drugs Standard Control Organisation (CDSCO) has released draft standards for In-Vitro Diagnostics (IVD) medical devices, inviting comments from stakeholders. Developed jointly with the Indian Council of Medical Research (ICMR), the protoc
Two intravenous (IV) doses of the antibiotic dalbavancin spaced seven days apart are just as effective at treating complicated Staphylococcus aureus bloodstream infections as daily IV doses of conventional antibiotics given over a period of four to
The US market expansion through the introduction of new products in the gastrointestinal, pain management, and digestive health division’s propelled the company's reported revenue of Rs. 620 crore, up 5% year over year
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
